Sotera Health Cash Flow Statement
SHC / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
$287M
FY2025
Free Cash Flow
$149M
FY2025
Capital Expenditures
$138M
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Sotera Health generated $287M in operating cash flow and $149M in free cash flow in FY2025. Free cash flow margin was 12.8% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
- High leverage: Debt-to-equity ratio of 3.53
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | $77.9M | $44.4M | $51.4M | -$233.6M | $116.9M | -$38.6M | -$20.9M |
| Depreciation & Amortization | $94.9M | $84.3M | $76.6M | $64.3M | $64.2M | $63.3M | $66.7M |
| Operating Cash Flow | $287.2M | $224.2M | -$147.7M | $278.0M | $281.5M | $120.6M | $149.0M |
| Capital Expenditures | $138.0M | $179.1M | $215.0M | $182.4M | $102.2M | $53.5M | $57.3M |
| Free Cash Flow | $149.2M | $45.1M | -$362.7M | $95.6M | $179.4M | $67.1M | $91.8M |
| Share Buybacks | - | - | - | $0 | $0 | $34.0M | $0 |
| Dividends Paid | - | - | - | - | $0 | $0 | $691.2M |
| FCF Margin | 12.8% | 4.1% | -34.6% | 9.5% | 19.3% | 8.2% | 11.8% |